| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Eidos Therapeutics Inc is a clinical development-stage biopharmaceutical company. It is focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR.
| |